Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.
Publicado el 3 de junio de 2020 · Inicio del retiro: 7 de abril de 2020
Resumen
FDA registra el retiro Z-2141-2020 de dispositivos médicos de Clase II, publicado el 3 de junio de 2020 e iniciado el 7 de abril de 2020. Empresa responsable: Inpeco S.A.; Estado: Finalizado; Cantidad reportada: 3 systems; Lote: Serial Numbers: ACP.290 ACP.343 ACP.365. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Inpeco S.A.
- Distribuidor
- US Nationwide including in the states of IL, NY.
- Lote
- Serial Numbers: ACP.290 ACP.343 ACP.365
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Switzerland
Retiros relacionados
- FDAAccelerator a3600 Automation System with the Aliquoter Module (Inpeco P/N FLX-212) The FlexLab (aka18 de noviembre de 2020
- FDAABL90 FLEX, model no. 393-090; and Spare Part Hemolyzer Units (902-980): R0526 - R0941 - Product Usage: are3 de junio de 2020
- FDABridge Occlusion Balloon, REF 590-001, QTY 1, Sheath Compatibility 12F, Guidewire Compatibility 0.035 in,3 de junio de 2020
- FDAInpeco FlexLab, ARCHITECT cSystem c8000/c16000 Interface Module, Part Numbers: FLX-208-00, FLX-208-10 -20 de mayo de 2020
- FDAAbbott Accelerator a3600 Centrifuge Module tube loading algorithm, Inpeco SA P/N: FLX-202, with Firmware13 de mayo de 2020
- FDAFlexLab, Accelerator a3600 and Aptio Automation are modular systems designed to automate Pre-Analytical and23 de noviembre de 2016
Preguntas sobre este retiro
¿Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2141-2020 el 3 de junio de 2020. Peligro reportado: The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter